Proteome Profiler Human Phospho-RTK Array Kit

データシート※最新のデータシートでない場合があります

• 商品コード：ARY001B
• メーカー：RSD
• 包装：1kit
• 価格： ¥133,000
• 在庫：2個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Lorenzon E et al. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Oncogene 2012 Jun;31(26):3136-47
  Lorenzon E et al
  2012/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 2
• 文献情報：
  Gowrishankar K et al. Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF/MEK inhibition. J. Invest. Dermatol. 2012 Jul;132(7):1850-9
  Gowrishankar K et al
  2012/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 3
• 文献情報：
  Ho AL et al. PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma. Cancer Res. 2012 Sep;72(17):4515-25
  Ho AL et al
  2012/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 4
• 文献情報：
  Kotani N et al. Fibroblast growth factor receptor 3 (FGFR3) associated with the CD20 antigen regulates the rituximab-induced proliferation inhibition in B-cell lymphoma cells. J. Biol. Chem. 2012 Oct;287(44):37109-18
  Kotani N et al
  2012/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 5
• 文献情報：
  Joshi AD et al. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy. PLoS ONE 2012;7(10):e44372
  Joshi AD et al
  2012/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 6
• 文献情報：
  Lin SP et al. Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27. PLoS ONE 2012;7(11):e49605
  Lin SP et al
  2012/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 7
• 文献情報：
  Duncan JS et al. Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell 2012 Apr;149(2):307-21
  Duncan JS et al
  2012/01/01
  
• 備考：
  Sample Type: Tissue Homogenates
• 参照：
  

• No.： 8
• 文献情報：
  Purushothaman A et al. Heparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma. J. Biol. Chem. 2012 Nov;287(49):41288-96
  Purushothaman A et al
  2012/01/01
  
• 備考：
  Sample Type: Cell Lysate
• 参照：
  

• No.： 9
• 文献情報：
  Montero JC et al. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer. Oncogene 2014 Jan;33(2):148-56
  Montero JC et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 10
• 文献情報：
  Britschgi A et al. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc. Natl. Acad. Sci. U.S.A. 2013 Mar;110(11):E1026-34
  Britschgi A et al
  2013/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 11
• 文献情報：
  Kwon HS et al. Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signaling. J. Biol. Chem. 2013 Sep;288(37):26357-71
  Kwon HS et al
  2013/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 12
• 文献情報：
  Ugurel S et al. Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up. Clin. Cancer Res. 2014 Jan;20(2):499-510
  Ugurel S et al
  2014/01/01
  
• 備考：
  Sample Type: Tissue Lysate
• 参照：
  

• No.： 13
• 文献情報：
  Lei H et al. A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α. Mol. Cell. Biol. 2014 Jan;34(1):110-22
  Lei H et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 14
• 文献情報：
  Son MY et al. Comparative receptor tyrosine kinase profiling identifies a novel role for AXL in human stem cell pluripotency. Hum. Mol. Genet. 2014 Apr;23(7):1802-16
  Son MY et al
  2014/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 15
• 文献情報：
  Drake JM et al. Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proc. Natl. Acad. Sci. U.S.A. 2013 Dec;110(49):E4762-9
  Drake JM et al
  2013/01/01
  
• 備考：
  Sample Type: Homogenized Tissue
• 参照：
  

• No.： 16
• 文献情報：
  Skoda J et al. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy. Oncol. Rep. 2014 Jan;31(1):480-7
  Skoda J et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 17
• 文献情報：
  de-Freitas-Junior JC et al. Insulin/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. an interplay with E-cadherin. PLoS ONE 2013;8(11):e81579
  de-Freitas-Junior JC et al
  2013/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 18
• 文献情報：
  Lekawanvijit S et al. The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction. PLoS ONE 2013;8(12):e83687
  Lekawanvijit S et al
  2013/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 19
• 文献情報：
  Carlino MS et al. Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma. Mol Oncol 2014 May;8(3):544-54
  Carlino MS et al
  2014/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 20
• 文献情報：
  Sakanyan V et al. Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells. Sci Rep 2014;4:3977
  Sakanyan V et al
  2014/01/01
  
• 備考：
  Application: Phosphorylation array, Sample Type: Cell Lysate
• 参照：
  

• No.： 21
• 文献情報：
  Camorani S et al. Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer. Mol. Ther. 2014 Apr;22(4):828-41
  Camorani S et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Extract
• 参照：
  

• No.： 22
• 文献情報：
  Banerjee J et al. Improvement of human keratinocyte migration by a redox active bioelectric dressing. PLoS ONE 2014;9(3):e89239
  Banerjee J et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 23
• 文献情報：
  Miyagawa-Yamaguchi A et al. Expressed glycosylphosphatidylinositol-anchored horseradish peroxidase identifies co-clustering molecules in individual lipid raft domains. PLoS ONE 2014;9(3):e93054
  Miyagawa-Yamaguchi A et al
  2014/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 24
• 文献情報：
  Cuenca-L坦pez MD et al. Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling. BMC Cancer 2014;14:302
  Cuenca-L坦pez MD et al
  2014/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 25
• 文献情報：
  Wang LK et al. MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS ONE 2014;9(5):e96765
  Wang LK et al
  2014/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 26
• 文献情報：
  Wang J et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene 2014 Jun;
  Wang J et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 27
• 文献情報：
  Outani H et al. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS. BMC Cancer 2014;14:455
  Outani H et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysate
• 参照：
  

• No.： 28
• 文献情報：
  Shiono M et al. Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality. Sci Rep 2014;4:5927
  Shiono M et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysate
• 参照：
  

• No.： 29
• 文献情報：
  Imura Y et al. Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma. Mol. Cancer 2014;13:185
  Imura Y et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 30
• 文献情報：
  Puzanov I et al. A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors. Clin. Cancer Res. 2015 Feb;21(4):701-11
  Puzanov I et al
  2015/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 31
• 文献情報：
  Zemskova MY et al. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. Cell. Signal. 2015 Jan;27(1):135-46
  Zemskova MY et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysate
• 参照：
  

• No.： 32
• 文献情報：
  Tworkoski K et al. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation. J. Virol. 2015 Mar;89(5):2590-602
  Tworkoski K et al
  2015/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 33
• 文献情報：
  Wu JR et al. Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways. PLoS ONE 2015;10(1):e0114495
  Wu JR et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 34
• 文献情報：
  Laukkanen MO et al. Extracellular superoxide dismutase regulates the expression of small gtpase regulatory proteins GEFs, GAPs, and GDI. PLoS ONE 2015;10(3):e0121441
  Laukkanen MO et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 35
• 文献情報：
  Ito K et al. Artificial human Met agonists based on macrocycle scaffolds. Nat Commun 2015;6:6373
  Ito K et al
  2015/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 36
• 文献情報：
  Broecker-Preuss M et al. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status. BMC Cancer 2015;15:184
  Broecker-Preuss M et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 37
• 文献情報：
  Lee H et al. Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migration. Mol. Cell. Biol. 2013 Apr;33(7):1430-41
  Lee H et al
  2013/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 38
• 文献情報：
  Li L et al. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII. Oncogene 2014 Aug;33(33):4253-64
  Li L et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 39
• 文献情報：
  Song W et al. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer. Cancer Res. 2014 May;74(9):2444-54
  Song W et al
  2014/01/01
  
• 備考：
  Sample Type: Cell Lysate
• 参照：
  

• No.： 40
• 文献情報：
  Calero R et al. Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis. PLoS ONE 2014;9(4):e95628
  Calero R et al
  2014/01/01
  
• 備考：
  Sample Type: Protien Lysates
• 参照：
  

• No.： 41
• 文献情報：
  Ji Z et al. MITF Modulates Therapeutic Resistance through EGFR Signaling. J. Invest. Dermatol. 2015 Jul;135(7):1863-72
  Ji Z et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 42
• 文献情報：
  Chung S et al. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array. PLoS ONE 2015;10(8):e0134948
  Chung S et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 43
• 文献情報：
  Song A et al. Molecular Changes Associated with Acquired Resistance to Crizotinib in ROS1-Rearranged Non-Small Cell Lung Cancer. Clin. Cancer Res. 2015 May;21(10):2379-87
  Song A et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 44
• 文献情報：
  Cohen NA et al. Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors. Cancer Res. 2015 May;75(10):2061-70
  Cohen NA et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 45
• 文献情報：
  Heim EN et al. Biologically active LIL proteins built with minimal chemical diversity. Proc. Natl. Acad. Sci. U.S.A. 2015 Aug;112(34):E4717-25
  Heim EN et al
  2015/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 46
• 文献情報：
  Yoshida T et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE 2016;11(1):e0147344
  Yoshida T et al
  2016/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 47
• 文献情報：
  Szymanska E et al. Impaired dynamin 2 function leads to increased AP-1 transcriptional activity through the JNK/c-Jun pathway. Cell. Signal. 2016 Jan;28(1):160-71
  Szymanska E et al
  2016/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 48
• 文献情報：
  Huang M et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J. Clin. Invest. 2016 May;126(5):1801-14
  Huang M et al
  2016/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 49
• 文献情報：
  Brandt A et al. Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15. PLoS ONE 2016;11(5):e0155561
  Brandt A et al
  2016/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 50
• 文献情報：
  Aghajanian H et al. Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor. Nat Commun 2016 Jun;7:12038
  Aghajanian H et al
  2016/01/01
  
• 備考：
  Sample Type: Whole Cells
• 参照：
  

• No.： 51
• 文献情報：
  Cassinelli G et al. Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases. Oncotarget 2016 Jul;7(30):47848-47863
  Cassinelli G et al
  2016/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 52
• 文献情報：
  Xu Y et al. FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases. Oncotarget 2016 Oct;7(43):70080-70091
  Xu Y et al
  2016/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 53
• 文献情報：
  Nanjo S et al. MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer. Mol. Cancer Ther. 2017 Mar;16(3):506-515
  Nanjo S et al
  2017/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 54
• 文献情報：
  Saintas E et al. Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS. PLoS ONE 2017;12(2):e01
  Saintas E et al
  2017/01/01
  
• 備考：
  Sample Type: Cell Lysate
• 参照：
  

• No.： 55
• 文献情報：
  Nukaga S et al. Amplification of EGFR Wild-Type Alleles in Non-Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors. Cancer Res. 2017 Apr;77(8):2078-2089
  Nukaga S et al
  2017/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 56
• 文献情報：
  Buchanan PC et al. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17. J. Biol. Chem. 2017 Apr;292(15):6339-6351
  Buchanan PC et al
  2017/01/01
  
• 備考：
  Sample Type: cell supernates
• 参照：
  

• No.： 57
• 文献情報：
  Li C et al. Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 2017 Apr;114(14):E2852-E2861
  Li C et al
  2017/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 58
• 文献情報：
  Yadav SS et al. Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications. Transl Oncol 2017 Jun;10(3):357-366
  Yadav SS et al
  2017/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 59
• 文献情報：
  Xu L et al. BCL6 promotes glioma and serves as a therapeutic target. Proc. Natl. Acad. Sci. U.S.A. 2017 04;114(15):3981-3986
  Xu L et al
  2017/01/01
  
• 備考：
  Sample Type: Cell Lysates
• 参照：
  

• No.： 60
• 文献情報：
  Adelaiye-Ogala R et al. EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming. Cancer Res. 2017 12;77(23):6651-6666
  Adelaiye-Ogala R et al
  2017/01/01
  
• 備考：
  Species: Mouse
• 参照：
  

• No.： 61
• 文献情報：
  Villanueva J et al. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell 2010 Dec;18(6):683-95
  Villanueva J et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 62
• 文献情報：
  Lupberger J et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 2011 May;17(5):589-95
  Lupberger J et al
  2011/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 63
• 文献情報：
  Noh K et al. Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis. Cell Rep 2017 Dec;21(10):2785-2795
  Noh K et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 64
• 文献情報：
  Chauvin C et al. High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors. Cell Rep 2017 Nov;21(7):1737-1745
  Chauvin C et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 65
• 文献情報：
  Bax DA et al. EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clin. Cancer Res. 2009 Sep;15(18):5753-61
  Bax DA et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 66
• 文献情報：
  Shimamura T et al. Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance. Cancer Res. 2008 Jul;68(14):5827-38
  Shimamura T et al
  2008/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 67
• 文献情報：
  Eckstein N et al. Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. Cancer Res. 2009 Apr;69(7):2996-3003
  Eckstein N et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 68
• 文献情報：
  Dewaele B et al. Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. Cancer Res. 2010 Sep;70(18):7304-14
  Dewaele B et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 69
• 文献情報：
  Marston E et al. Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response. Blood 2009 Jan;113(1):117-26
  Marston E et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 70
• 文献情報：
  Davies KD et al. Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer. PLoS ONE 2013;8(12):e82236
  Davies KD et al
  2013/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 71
• 文献情報：
  Oliveras-Ferraros C et al. Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin). Int. J. Oncol. 2010 Sep;37(3):669-78
  Oliveras-Ferraros C et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 72
• 文献情報：
  Koivunen JP et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin. Cancer Res. 2008 Jul;14(13):4275-83
  Koivunen JP et al
  2008/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 73
• 文献情報：
  Buck E et al. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res. 2008 Oct;68(20):8322-32
  Buck E et al
  2008/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 74
• 文献情報：
  Wang L et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 2007 Dec;110(12):4111-9
  Wang L et al
  2007/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 75
• 文献情報：
  Oliveras-Ferraros C et al. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells. Br. J. Cancer 2012 Apr;106(8):1406-14
  Oliveras-Ferraros C et al
  2012/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 76
• 文献情報：
  Godshalk SE et al. A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma. Oncogene 2011 Mar;30(13):1542-50
  Godshalk SE et al
  2011/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 77
• 文献情報：
  Engelman JA et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007 May;316(5827):1039-43
  Engelman JA et al
  2007/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 78
• 文献情報：
  Mansouri R et al. Osteoblastic heparan sulfate glycosaminoglycans control bone remodeling by regulating Wnt signaling and the crosstalk between bone surface and marrow cells. Cell Death Dis 2017 06;8(6):e2902
  Mansouri R et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 79
• 文献情報：
  Daneshmanesh AH et al. A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib. PLoS ONE 2018;13(6):e0198038
  Daneshmanesh AH et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 80
• 文献情報：
  Oura K et al. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest. Oncol. Rep. 2017 Nov;38(5):2825-2835
  Oura K et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 81
• 文献情報：
  Tang WH et al. Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. J. Clin. Invest. 2011 Nov;121(11):4462-76
  Tang WH et al
  2011/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 82
• 文献情報：
  Tani T et al. Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells. Mol. Cancer Ther. 2016 Jan;15(1):162-71
  Tani T et al
  2016/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 83
• 文献情報：
  Flanigan SA et al. The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models. Clin. Cancer Res. 2010 Nov;16(22):5436-46
  Flanigan SA et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 84
• 文献情報：
  Malchers F et al. Mechanisms of Primary Drug Resistance in <i>FGFR1</i>-Amplified Lung Cancer. Clin. Cancer Res. 2017 Sep;23(18):5527-5536
  Malchers F et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 85
• 文献情報：
  Carrasco-Garc鱈a E et al. Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines. Exp. Cell Res. 2011 Jun;317(10):1476-89
  Carrasco-Garc鱈a E et al
  2011/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 86
• 文献情報：
  Agarwal S et al. Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells. Br. J. Cancer 2009 Mar;100(6):941-9
  Agarwal S et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 87
• 文献情報：
  Eckstein N et al. Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 2008 Jan;283(2):739-50
  Eckstein N et al
  2008/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 88
• 文献情報：
  Kawaguchi K et al. Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells. Carcinogenesis 2009 Jul;30(7):1097-105
  Kawaguchi K et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 89
• 文献情報：
  Donson AM et al. Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma. Mol. Cancer Ther. 2018 Sep;17(9):1984-1994
  Donson AM et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 90
• 文献情報：
  Haas B et al. Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs. Cancer Cell Int. 2018;18:69
  Haas B et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 91
• 文献情報：
  Chen W et al. Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors. Cancer Res. 2017 09;77(18):5107-5117
  Chen W et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 92
• 文献情報：
  Stacchiotti S et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol. Cancer Ther. 2010 May;9(5):1286-97
  Stacchiotti S et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 93
• 文献情報：
  Stommel JM et al. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 2007 Oct;318(5848):287-90
  Stommel JM et al
  2007/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 94
• 文献情報：
  Ninomiya K et al. MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib. Sci Rep 2018 Jan;8(1):1955
  Ninomiya K et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 95
• 文献情報：
  Kang HG et al. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 2007 Apr;67(7):3094-105
  Kang HG et al
  2007/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 96
• 文献情報：
  Negri T et al. Functional mapping of receptor tyrosine kinases in myxoid liposarcoma. Clin. Cancer Res. 2010 Jul;16(14):3581-93
  Negri T et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 97
• 文献情報：
  Suda K et al. Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer. Clin. Cancer Res. 2010 Nov;16(22):5489-98
  Suda K et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 98
• 文献情報：
  Fujikawa T et al. Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J. Biol. Chem. 2007 Mar;282(12):8741-8
  Fujikawa T et al
  2007/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 99
• 文献情報：
  Str旦bel P et al. Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br. J. Cancer 2010 Jul;103(2):196-200
  Str旦bel P et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 100
• 文献情報：
  Nazarian R et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 2010 Dec;468(7326):973-7
  Nazarian R et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 101
• 文献情報：
  Ding W et al. Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch. Blood 2010 Oct;116(16):2984-93
  Ding W et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 102
• 文献情報：
  Henriksson ML et al. Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion. Am. J. Pathol. 2011 Mar;178(3):1387-94
  Henriksson ML et al
  2011/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 103
• 文献情報：
  Kotani H et al. Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers. Oncogene 2018 Mar;37(13):1775-1787
  Kotani H et al
  2018/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 104
• 文献情報：
  Kobayashi T et al. Transactivation of RON receptor tyrosine kinase by interaction with PDGF receptor beta during steady-state growth of human mesangial cells. Kidney Int. 2009 Jun;75(11):1173-83
  Kobayashi T et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 105
• 文献情報：
  Kang HG et al. Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells. Mol. Cancer Ther. 2010 May;9(5):1396-407
  Kang HG et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 106
• 文献情報：
  McKinley ET et al. 18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer. Clin. Cancer Res. 2011 May;17(10):3332-40
  McKinley ET et al
  2011/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 107
• 文献情報：
  Eiselleova L et al. A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 2009 Aug;27(8):1847-57
  Eiselleova L et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 108
• 文献情報：
  Cohen EE et al. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res. 2006 Jun;66(12):6296-303
  Cohen EE et al
  2006/01/01
  
• 備考：
  
• 参照：
  

• No.： 109
• 文献情報：
  Yoon YK et al. Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells. Mol. Cancer Ther. 2009 Sep;8(9):2526-36
  Yoon YK et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 110
• 文献情報：
  Stacchiotti S et al. Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin. Cancer Res. 2009 Feb;15(3):1096-104
  Stacchiotti S et al
  2009/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 111
• 文献情報：
  Vultur A et al. MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines. Oncogene 2014 Apr;33(14):1850-61
  Vultur A et al
  2014/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 112
• 文献情報：
  Lyons A et al. Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells. J. Biol. Chem. 2017 10;292(41):16983-16998
  Lyons A et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 113
• 文献情報：
  Yamaguchi T et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun 2016;7:10060
  Yamaguchi T et al
  2016/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 114
• 文献情報：
  Lampada A et al. mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism. Cell Death Differ. 2017 06;24(6):1045-1062
  Lampada A et al
  2017/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 115
• 文献情報：
  Roorda BD et al. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms. Eur. J. Cancer 2010 Mar;46(5):974-82
  Roorda BD et al
  2010/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 116
• 文献情報：
  Yu L et al. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas. Mol. Med. ;14(5-6):264-75
  Yu L et al
  
• 備考：
  Species: Human
• 参照：
  

• No.： 117
• 文献情報：
  Lomas AC et al. Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activation. Biochem. J. 2007 Aug;405(3):417-28
  Lomas AC et al
  2007/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 118
• 文献情報：
  Fan PD et al. <i>YES1</i> amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc. Natl. Acad. Sci. U.S.A. 2018 06;115(26):E6030-E6038
  Fan PD et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 119
• 文献情報：
  Fukuda K et al. Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of <i>ALK</i> Mutation Status. Cancer Res. 2019 Apr;79(7):1658-1670
  Fukuda K et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 120
• 文献情報：
  Linkous A et al. Modeling Patient-Derived Glioblastoma with Cerebral Organoids. Cell Rep 2019 Mar;26(12):3203-3211.e5
  Linkous A et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 121
• 文献情報：
  Owusu BY et al. Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation. Oncotarget 2017 Sep;8(38):63014-63025
  Owusu BY et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 122
• 文献情報：
  Y叩ng端ez E et al. Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun 2018 09;9(1):3679
  Y叩ng端ez E et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 123
• 文献情報：
  Sun S et al. HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation. Cell Death Dis 2018 Sep;9(9):929
  Sun S et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 124
• 文献情報：
  Fang Z et al. Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-&#x3B2;/STAT3 Pathway. Cell. Physiol. Biochem. 2018;47(5):1751-1768
  Fang Z et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 125
• 文献情報：
  Sramek M et al. Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a <i>PDGFRB</i> Mutation Associated with Infantile Myofibromatosis. Int J Mol Sci 2018 Sep;19(9)
  Sramek M et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 126
• 文献情報：
  Painuly U et al. Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma. Oncotarget 2018 Oct;9(77):34582-34594
  Painuly U et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 127
• 文献情報：
  Graves-Deal R et al. Broad-spectrum receptor tyrosine kinase inhibitors overcome <i>de novo</i> and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer. Oncotarget 2019 Feb;10(13):1320-1333
  Graves-Deal R et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 128
• 文献情報：
  Choi SH et al. Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6⁺ cancer cell and macrophage polarization. Nat Commun 2018 11;9(1):5108
  Choi SH et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 129
• 文献情報：
  Xiao Z et al. Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach. Oncotarget 2019 Apr;10(26):2546-2560
  Xiao Z et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 130
• 文献情報：
  He L et al. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis. J. Exp. Clin. Cancer Res. 2019 Feb;38(1):84
  He L et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 131
• 文献情報：
  Heliste J et al. Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target. BMC Cardiovasc Disord 2018 10;18(1):196
  Heliste J et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 132
• 文献情報：
  Wang X et al. The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors. Mol. Cancer Ther. 2019 Mar;18(3):667-679
  Wang X et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 133
• 文献情報：
  Boichuk S et al. Targeting of FGF-Signaling Re-Sensitizes Gastrointestinal Stromal Tumors (GIST) to Imatinib In Vitro and In Vivo. Molecules 2018 Oct;23(10)
  Boichuk S et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 134
• 文献情報：
  Ahmed TA et al. SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors. Cell Rep 2019 Jan;26(1):65-78.e5
  Ahmed TA et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 135
• 文献情報：
  Menendez JA et al. Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression. J. Clin. Oncol. 2006 Aug;24(23):3735-46
  Menendez JA et al
  2006/01/01
  
• 備考：
  
• 参照：
  

• No.： 136
• 文献情報：
  Kurimchak AM et al. Intrinsic Resistance to MEK Inhibition through BET Protein-Mediated Kinome Reprogramming in NF1-Deficient Ovarian Cancer. Mol. Cancer Res. 2019 Aug;17(8):1721-1734
  Kurimchak AM et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 137
• 文献情報：
  Aarnio-Peterson M et al. Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting. J. Biol. Chem. 2017 09;292(36):15094-15104
  Aarnio-Peterson M et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 138
• 文献情報：
  Chakrabarty A et al. Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors. Proc. Natl. Acad. Sci. U.S.A. 2012 Feb;109(8):2718-23
  Chakrabarty A et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 139
• 文献情報：
  Herr R et al. BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines. Oncogene 2018 Mar;37(12):1576-1593
  Herr R et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 140
• 文献情報：
  Agaram NP et al. Molecular characterization of pediatric gastrointestinal stromal tumors. Clin. Cancer Res. 2008 May;14(10):3204-15
  Agaram NP et al
  2008/01/01
  
• 備考：
  
• 参照：
  

• No.： 141
• 文献情報：
  Kunii K et al. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. Cancer Res. 2008 Apr;68(7):2340-8
  Kunii K et al
  2008/01/01
  
• 備考：
  
• 参照：
  

• No.： 142
• 文献情報：
  Kashiwagi K et al. A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells. Life Sci. 2009 May;84(19-20):650-6
  Kashiwagi K et al
  2009/01/01
  
• 備考：
  
• 参照：
  

• No.： 143
• 文献情報：
  Krzyzaniak MA et al. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 2013;9(4):e1003309
  Krzyzaniak MA et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 144
• 文献情報：
  Patwardhan PP et al. Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma. Mol. Cancer Ther. 2018 11;17(11):2329-2340
  Patwardhan PP et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 145
• 文献情報：
  Ball SG et al. Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency. Stem Cells 2012 Mar;30(3):548-60
  Ball SG et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 146
• 文献情報：
  Bai Y et al. Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res. 2012 May;72(10):2501-11
  Bai Y et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 147
• 文献情報：
  Chen ST et al. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway. Oncogene 2018 Jul;
  Chen ST et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 148
• 文献情報：
  Tanizaki J et al. Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification. Br. J. Cancer 2011 Sep;105(6):807-13
  Tanizaki J et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 149
• 文献情報：
  Greenall SA et al. Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3. Transl Oncol 2018 Aug;11(4):971-978
  Greenall SA et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 150
• 文献情報：
  Klameth L et al. In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines. J Cancer 2017;8(10):1733-1743
  Klameth L et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 151
• 文献情報：
  van der Waals LM et al. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures. Sci Rep 2019 Jan;9(1):819
  van der Waals LM et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 152
• 文献情報：
  Mueller KL et al. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res. 2008 May;68(9):3314-22
  Mueller KL et al
  2008/01/01
  
• 備考：
  
• 参照：
  

• No.： 153
• 文献情報：
  Leonard B et al. BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC. Cancer Res. 2018 Aug;78(15):4331-4343
  Leonard B et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 154
• 文献情報：
  Okon IS et al. Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells. J. Biol. Chem. 2014 Jan;289(3):1639-48
  Okon IS et al
  2014/01/01
  
• 備考：
  
• 参照：
  

• No.： 155
• 文献情報：
  Mao F et al. Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma. Oncogenesis 2018 Feb;7(2):13
  Mao F et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 156
• 文献情報：
  Pearson HE et al. Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol. Mol. Cancer Ther. 2018 01;17(1):204-214
  Pearson HE et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 157
• 文献情報：
  Ciaglia E et al. Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. Int. J. Cancer 2017 02;140(4):959-972
  Ciaglia E et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 158
• 文献情報：
  Karki R et al. The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation. PLoS Pathog. 2011 Apr;7(4):e1001331
  Karki R et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 159
• 文献情報：
  Jin HO et al. Piperlongumine downregulates the expression of HER family in breast cancer cells. Biochem. Biophys. Res. Commun. 2017 May;486(4):1083-1089
  Jin HO et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 160
• 文献情報：
  Jung SN et al. LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals. Sci Rep 2018 Feb;8(1):2718
  Jung SN et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 161
• 文献情報：
  Goldoni S et al. Decorin is a novel antagonistic ligand of the Met receptor. J. Cell Biol. 2009 May;185(4):743-54
  Goldoni S et al
  2009/01/01
  
• 備考：
  
• 参照：
  

• No.： 162
• 文献情報：
  Ou WB et al. Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma. Neoplasia 2011 Jan;13(1):12-22
  Ou WB et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 163
• 文献情報：
  Sin STK et al. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling. Gynecol. Oncol. 2019 01;152(1):185-193
  Sin STK et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 164
• 文献情報：
  Hsu HP et al. Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling. Sci Rep 2017 Jul;7(1):5823
  Hsu HP et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 165
• 文献情報：
  Tanabe H et al. Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2. Int. J. Oncol. 2011 Jul;39(1):33-40
  Tanabe H et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 166
• 文献情報：
  Rao S et al. A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers. J. Biol. Chem. 2019 May;294(21):8664-8673
  Rao S et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 167
• 文献情報：
  Ganesh K et al. Prostaglandin E&#x2082; induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway. J. Immunol. 2012 Sep;189(5):2563-73
  Ganesh K et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 168
• 文献情報：
  Wang D et al. Protein C receptor stimulates multiple signaling pathways in breast cancer cells. J. Biol. Chem. 2018 01;293(4):1413-1424
  Wang D et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 169
• 文献情報：
  Ball SG et al. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J. Cell Biol. 2007 May;177(3):489-500
  Ball SG et al
  2007/01/01
  
• 備考：
  
• 参照：
  

• No.： 170
• 文献情報：
  Csepeggi C et al. Somatic cell plasticity and Niemann-pick type C2 protein: adipocyte differentiation and function. J. Biol. Chem. 2010 Sep;285(39):30347-54
  Csepeggi C et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 171
• 文献情報：
  Miyata K et al. Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation. Sci Rep 2017 Jun;7(1):4059
  Miyata K et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 172
• 文献情報：
  Jang WJ et al. Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3. J. Cell. Mol. Med. 2019 Feb;23(2):1106-1115
  Jang WJ et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 173
• 文献情報：
  Poulikakos PI et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 2011 Dec;480(7377):387-90
  Poulikakos PI et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 174
• 文献情報：
  Virz狸 AR et al. Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation. Proc. Natl. Acad. Sci. U.S.A. 2018 10;115(40):10058-10063
  Virz狸 AR et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 175
• 文献情報：
  Cook SA et al. Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur. Heart J. 2010 Jan;31(1):100-11
  Cook SA et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 176
• 文献情報：
  Franovic A et al. Human cancers converge at the HIF-2alpha oncogenic axis. Proc. Natl. Acad. Sci. U.S.A. 2009 Dec;106(50):21306-11
  Franovic A et al
  2009/01/01
  
• 備考：
  
• 参照：
  

• No.： 177
• 文献情報：
  Csepeggi C et al. Somatic cell plasticity and Niemann-Pick type C2 protein: fibroblast activation. J. Biol. Chem. 2011 Jan;286(3):2078-87
  Csepeggi C et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 178
• 文献情報：
  Ding VM et al. Tyrosine phosphorylation profiling in FGF-2 stimulated human embryonic stem cells. PLoS ONE 2011;6(3):e17538
  Ding VM et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 179
• 文献情報：
  Jiao Y et al. Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation. Mol. Cancer 2011;10:125
  Jiao Y et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 180
• 文献情報：
  Sulahian R et al. Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers. Cell Rep 2019 10;29(1):118-134.e8
  Sulahian R et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 181
• 文献情報：
  Nakai S et al. Establishment of a novel human CIC-DUX₄ sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs. Sci Rep 2019 11;9(1):15812
  Nakai S et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 182
• 文献情報：
  Manabe T et al. IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer. Mol Cancer Res 2020 04;18(4):549-559
  Manabe T et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 183
• 文献情報：
  Matsui T et al. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo. Int J Mol Sci 2019 Jun;20(13)
  Matsui T et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 184
• 文献情報：
  Skoda J et al. Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells. Cancers (Basel) 2020 Jan;12(1)
  Skoda J et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 185
• 文献情報：
  Sato T et al. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma. Cancer Res 2019 12;79(24):6084-6100
  Sato T et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 186
• 文献情報：
  Njah K et al. A Role of Agrin in Maintaining the Stability of Vascular Endothelial Growth Factor Receptor-2 during Tumor Angiogenesis. Cell Rep 2019 07;28(4):949-965.e7
  Njah K et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 187
• 文献情報：
  Meng F et al. EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming. Nat Commun 2019 11;10(1):5033
  Meng F et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 188
• 文献情報：
  Kuo MT et al. Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors. Transl Oncol 2020 Feb;13(2):355-364
  Kuo MT et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 189
• 文献情報：
  Lee N et al. 2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met. Metabolites 2019 Sep;9(9)
  Lee N et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 190
• 文献情報：
  MacFarland SP et al. Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft Model. Mol Cancer Ther 2020 03;19(3):920-926
  MacFarland SP et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 191
• 文献情報：
  Zhang Q et al. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas. BMC Cancer 2019 Nov;19(1):1044
  Zhang Q et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 192
• 文献情報：
  de Laat MA et al. An investigation of the equine epidermal growth factor system during hyperinsulinemic laminitis. PLoS One 2019;14(12):e0225843
  de Laat MA et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 193
• 文献情報：
  Kim J et al. STAT3 Relays a Differential Response to Melanoma-Associated <i>NRAS</i> Mutations. Cancers (Basel) 2020 Jan;12(1)
  Kim J et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 194
• 文献情報：
  Lee J et al. Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression. Cancers (Basel) 2020 Jan;12(2)
  Lee J et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 195
• 文献情報：
  Singh N et al. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells. Nat Med 2021 05;27(5):842-850
  Singh N et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 196
• 文献情報：
  Yanagitani N et al. Drug resistance mechanisms in Japanese anaplastic lymphoma kinase-positive non-small cell lung cancer and the clinical responses based on the resistant mechanisms. Cancer Sci 2020 Mar;111(3):932-939
  Yanagitani N et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 197
• 文献情報：
  Pietrobono S et al. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nat Commun 2020 11;11(1):5865
  Pietrobono S et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 198
• 文献情報：
  Mahdal M et al. New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFR&#x3B2; Signaling. Cancers (Basel) 2021 Jul;13(14)
  Mahdal M et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 199
• 文献情報：
  Fuentes-Baile M et al. Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines. Cancers (Basel) 2020 Dec;12(12)
  Fuentes-Baile M et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 200
• 文献情報：
  Zhang P et al. Effect of cyclic mechanical loading on immunoinflammatory microenvironment in biofabricating hydroxyapatite scaffold for bone regeneration. Bioact Mater 2021 Oct;6(10):3097-3108
  Zhang P et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 201
• 文献情報：
  Morishita A et al. Galectin&#x2011;9 suppresses the tumor growth of colon cancer <i>in&#xA0;vitro</i> and <i>in&#xA0;vivo</i>. Oncol Rep 2021 Jun;45(6)
  Morishita A et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 202
• 文献情報：
  Areeb Z et al. Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma. Sci Rep 2020 10;10(1):17768
  Areeb Z et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 203
• 文献情報：
  Lee PC et al. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer. Oncogene 2020 03;39(13):2724-2740
  Lee PC et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 204
• 文献情報：
  Roy S et al. MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Cancers (Basel) 2020 Aug;12(8)
  Roy S et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 205
• 文献情報：
  Holl坦si P et al. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1. Biomolecules 2020 09;10(10)
  Holl坦si P et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 206
• 文献情報：
  Zhou B et al. Extracellular SQSTM1 mediates bacterial septic death in mice through insulin receptor signalling. Nat Microbiol 2020 12;5(12):1576-1587
  Zhou B et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 207
• 文献情報：
  Lee SJ et al. Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling. Cancers (Basel) 2021 Jun;13(11)
  Lee SJ et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 208
• 文献情報：
  Lee J et al. Identification of Phospho-Tyrosine Targets as a Strategy for the Treatment of Esophageal Adenocarcinoma Cells. Onco Targets Ther 2021;14:3813-3820
  Lee J et al
  2021/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 209
• 文献情報：
  Cheng CL et al. CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway. Cells 2020 07;9(7)
  Cheng CL et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 210
• 文献情報：
  Liao WC et al. Chondroitin sulfate synthase 1 enhances proliferation of glioblastoma by modulating PDGFRA stability. Oncogenesis 2020 Feb;9(2):9
  Liao WC et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 211
• 文献情報：
  Lee ES et al. Sarmentosamide, an Anti-Aging Compound from a Marine-Derived <i>Streptomyces</i> sp. APmarine042. Mar Drugs 2020 Sep;18(9)
  Lee ES et al
  2020/01/01
  
• 備考：
  Species: Human
• 参照：